$ABBV

AI 分析

生成于 May 18, 2026

AI Score
74/ 100
Buy$ABBV

AbbVie Inc.

$ABBVNYSEHealthcareLarge-Cap

AbbVie discovers, develops, manufactures, and sells pharmaceuticals worldwide focusing on immunology, oncology, and neuroscience.

Market Cap
$340B
Revenue (TTM)
$58.2B
+5.8%
Net Income (TTM)
$8.5B
+22.5%
EPS (TTM)
$4.82
P/E Ratio
38.5
Dividend Yield
3.2%
52-Week Range
$155-$205
Beta
0.58
Dimension Scores
Fundamental
78
Technical
70
Sentiment
74
Risk / Reward
75
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
75moderate
Growth
72moderate
Liquidity
70moderate
Solvency
65moderate
Efficiency
76moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $ABBV

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。